ArticleFrontiers in neurology2020
Genetic and Phenotypic Basis of Autosomal Dominant Parkinson's Disease in a Large Multi-Center Cohort.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.
- Neuroinflammation in Parkinson's Disease: From Gene to Clinic: A Systematic Review.International journal of molecular sciences · 2023Pooled it
- Tracking Genetic Parkinson's Disease with Molecular Imaging: A Systematic Review.Movement disorders clinical practice · 2026Review
- Rab8a dysregulation in Parkinson's disease: A convergence of genetic and molecular pathologies.Molecular biology reports · 2026Review
- Recent advances in targeting LRRK2 for Parkinson's disease treatment.Journal of translational medicine · 2025Review
- Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background.Biomedicines · 2025Review
- Article
- The Leucine-Rich Repeat Kinase 2 Variant LRRK2International journal of molecular sciences · 2025Article
- Absence of theFrontiers in aging neuroscience · 2025Article
- Navigating the Neurobiology of Parkinson's: The Impact and Potential of α-Synuclein.Biomedicines · 2024Review
- Neurocognitive Impairment and Social Cognition in Parkinson's Disease Patients.Neurology international · 2024Review
- Parkinson's Disease is Predominantly a Genetic Disease.Journal of Parkinson's disease · 2024Review
- Parkinson's disease updates: Addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment.Annals of medicine and surgery (2012) · 2023Review
- In Silico Evaluation of the Potential Association of the Pathogenic Mutations of Alpha Synuclein Protein with Induction of Synucleinopathies.Diseases (Basel, Switzerland) · 2023Article
- Parkinson's disease relevant pathological features are manifested in male Pink1/Parkin deficient rats.Brain, behavior, & immunity - health · 2023Article
- Brain-Biomarker Changes in Body Fluids of Patients with Parkinson's Disease.International journal of molecular sciences · 2023Review
- Parkinson's Disease: Exploring Different Animal Model Systems.International journal of molecular sciences · 2023Review
- Detection ofMovement disorders clinical practice · 2023Article
- Genetic Study of Early Onset Parkinson's Disease in Cyprus.International journal of molecular sciences · 2022Article
- Monogenic Parkinson's Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing.Genes · 2022Review
- Genetic architecture of Parkinson's disease subtypes - Review of the literature.Frontiers in aging neuroscience · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors at 16 institutions in 3 countries.
Suzanne LesageSorbonne Université, Unité Mixte de Recherche (UMR) 1127, Paris, France.
Marion HouotInstitut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Centre d'Excellence sur les Maladies Neurodégénératives (CoEN), Assistance Publique - Hôpitaux de Paris (AP-HP), Département de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, Université Paris 6, Paris, France.
Graziella MangoneSorbonne Université, Unité Mixte de Recherche (UMR) 1127, Paris, France.
Christelle TessonSorbonne Université, Unité Mixte de Recherche (UMR) 1127, Paris, France.
Hélène BertrandSorbonne Université, Unité Mixte de Recherche (UMR) 1127, Paris, France.
Sylvie ForlaniSorbonne Université, Unité Mixte de Recherche (UMR) 1127, Paris, France.
Mathieu AnheimDépartement de Neurologie aux Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Christine Brefel-CourbonService de Pharmacologie Clinique, Faculté de Médecine, Hôpital Universitaire, Toulouse, France.
Emmanuel BroussolleUniversité de Lyon, Institut des Sciences Cognitives Marc-Jeannerod, Unité Mixte de Recherche (UMR) 5229, Centre National de la Recherche Scientifique (CNRS), Bron, France.
Stéphane ThoboisUniversité de Lyon, Institut des Sciences Cognitives Marc-Jeannerod, Unité Mixte de Recherche (UMR) 5229, Centre National de la Recherche Scientifique (CNRS), Bron, France.
Philippe DamierCentre Hospitalier Universitaire de Nantes, Centre d'Investigation Clinique, Nantes, France.
Franck DurifDépartement de Neurologie A, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France.
Emmanuel RozeSorbonne Université, Unité Mixte de Recherche (UMR) 1127, Paris, France.
François TisonInstitut des Maladies Neurodégénératives, Centre Hospitalier Universitaire et Université de Bordeaux, Bordeaux, France.
David GrabliSorbonne Université, Unité Mixte de Recherche (UMR) 1127, Paris, France.
Fabienne Ory-MagneCentre de Neuroimagerie de Toulouse, Université de Toulouse - Institut National de la Santé et de la Recherche Médicale (INSERM) - Université de Toulouse, Toulouse, France.
Bertrand DegosUnité de Neurologie, Hôpital Universitaire Avicenne, Hôpitaux Universitaires de Paris-Seine Saint Denis, Assistance Publique - Hôpitaux de Paris (AP-HP), Sorbonne Paris Nord, Bobigny, France.
François VialletDépartement de Neurologie, Centre Hospitalier Intercommunal d'Aix-Pertuis, Aix-en-Provence, France.
Florence Cormier-DequaireSorbonne Université, Unité Mixte de Recherche (UMR) 1127, Paris, France.
Anne-Marie Ouvrard-HernandezCentre Hospitalier Universitaire de Grenoble, Service de Neurologie, Grenoble, France.
Marie VidailhetSorbonne Université, Unité Mixte de Recherche (UMR) 1127, Paris, France.
Ebba LohmannDepartment of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Andrew SingletonLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, United States.
Jean-Christophe CorvolSorbonne Université, Unité Mixte de Recherche (UMR) 1127, Paris, France.
Alexis BriceSorbonne Université, Unité Mixte de Recherche (UMR) 1127, Paris, France.
French Parkinson disease Genetics Study Group(PDG)
Inserm · FRSorbonne Université · FRAix-Marseille Université · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRCentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Universitaire de Nantes · FRCentre National de la Recherche Scientifique · FRCollège de France · FRHertie Institute for Clinical Brain Research · DEHôpital Paule de Viguier · FRHospices Civils de Lyon · FRInstitut des Maladies Neurodégénératives · FRInstitut des Sciences Cognitives · FRNational Institute on Aging · USUniversité de Strasbourg · FR
Funding
Genome wide SNP analysis in Parkinson's diseaseZ01AG000949 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW B · 2006 to 2008
$2.6MIntramural NIH HHS Z01 AG000949
Abstract
PubMed holds no abstract for this paper.
Indexed as
autosomal dominant inheritanceG2019Sgenotype-phenotype correlationsLRRK2Parkinson's diseaseSNCAVPS35
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.